Cargando…

Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)

INTRODUCTION: Current non-invasive treatments for erectile dysfunction (ED) include oral medications, intracavernosal injections, and vacuum-assisted devices. Though these therapies work well for many, a subset of patients have contraindications or are unsatisfied with these options. Restorative the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, James L., Chu, Kevin Y., Gabrielson, Andrew T., Wang, Run, Trost, Landon, Broderick, Gregory, Davies, Kelvin, Brock, Gerald, Mulhall, John, Ramasamy, Ranjith, Bivalacqua, Trinity J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240368/
https://www.ncbi.nlm.nih.gov/pubmed/34000480
http://dx.doi.org/10.1016/j.esxm.2021.100343
_version_ 1783715201845035008
author Liu, James L.
Chu, Kevin Y.
Gabrielson, Andrew T.
Wang, Run
Trost, Landon
Broderick, Gregory
Davies, Kelvin
Brock, Gerald
Mulhall, John
Ramasamy, Ranjith
Bivalacqua, Trinity J.
author_facet Liu, James L.
Chu, Kevin Y.
Gabrielson, Andrew T.
Wang, Run
Trost, Landon
Broderick, Gregory
Davies, Kelvin
Brock, Gerald
Mulhall, John
Ramasamy, Ranjith
Bivalacqua, Trinity J.
author_sort Liu, James L.
collection PubMed
description INTRODUCTION: Current non-invasive treatments for erectile dysfunction (ED) include oral medications, intracavernosal injections, and vacuum-assisted devices. Though these therapies work well for many, a subset of patients have contraindications or are unsatisfied with these options. Restorative therapies for ED are a new frontier of treatments focused on regenerating diseased tissue and providing a potential “cure” for ED. AIM: The aim of this position statement is to examine existing clinical trial data for restorative therapies and identify elements that require further research before widespread adoption. METHODS: A literature review was performed to identify all clinical trials performed with regenerative therapy for ED. This includes treatments such as stem cell therapy (SCT), platelet rich plasma (PRP), and restorative related technologies like low-intensity shockwave therapy (LiSWT). MAIN OUTCOME MEASURES: Most clinical trials in restorative therapies were assessed for safety, feasibility, or efficacy. This included recording adverse events, changes in sexual function and erectile function questionnaires, and diagnostics measures. RESULTS: To date there is an absence of robust clinical data supporting the efficacy of restorative therapies regarding ED, though technologies such as LiSWT have established relative safety. CONCLUSIONS: Restorative therapies are a promising technology that represents a new frontier of treatment geared towards reversing disease pathology rather than just treating symptoms. However, current published clinical studies are limited. Future work needs to be adequately powered, multi-center, randomized, sham/placebo-controlled trials in well-characterized patient populations to ensure safety and demonstrate efficacy. Until these studies are done, restorative therapies should be reserved for clinical trials and not offered in routine clinical practice. Liu JL, Chu KY, Gabrielson AT, et al. Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA). J Sex Med 2021;9:100343
format Online
Article
Text
id pubmed-8240368
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82403682021-06-29 Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA) Liu, James L. Chu, Kevin Y. Gabrielson, Andrew T. Wang, Run Trost, Landon Broderick, Gregory Davies, Kelvin Brock, Gerald Mulhall, John Ramasamy, Ranjith Bivalacqua, Trinity J. Sex Med Society Report INTRODUCTION: Current non-invasive treatments for erectile dysfunction (ED) include oral medications, intracavernosal injections, and vacuum-assisted devices. Though these therapies work well for many, a subset of patients have contraindications or are unsatisfied with these options. Restorative therapies for ED are a new frontier of treatments focused on regenerating diseased tissue and providing a potential “cure” for ED. AIM: The aim of this position statement is to examine existing clinical trial data for restorative therapies and identify elements that require further research before widespread adoption. METHODS: A literature review was performed to identify all clinical trials performed with regenerative therapy for ED. This includes treatments such as stem cell therapy (SCT), platelet rich plasma (PRP), and restorative related technologies like low-intensity shockwave therapy (LiSWT). MAIN OUTCOME MEASURES: Most clinical trials in restorative therapies were assessed for safety, feasibility, or efficacy. This included recording adverse events, changes in sexual function and erectile function questionnaires, and diagnostics measures. RESULTS: To date there is an absence of robust clinical data supporting the efficacy of restorative therapies regarding ED, though technologies such as LiSWT have established relative safety. CONCLUSIONS: Restorative therapies are a promising technology that represents a new frontier of treatment geared towards reversing disease pathology rather than just treating symptoms. However, current published clinical studies are limited. Future work needs to be adequately powered, multi-center, randomized, sham/placebo-controlled trials in well-characterized patient populations to ensure safety and demonstrate efficacy. Until these studies are done, restorative therapies should be reserved for clinical trials and not offered in routine clinical practice. Liu JL, Chu KY, Gabrielson AT, et al. Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA). J Sex Med 2021;9:100343 Elsevier 2021-05-14 /pmc/articles/PMC8240368/ /pubmed/34000480 http://dx.doi.org/10.1016/j.esxm.2021.100343 Text en Copyright © 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Society Report
Liu, James L.
Chu, Kevin Y.
Gabrielson, Andrew T.
Wang, Run
Trost, Landon
Broderick, Gregory
Davies, Kelvin
Brock, Gerald
Mulhall, John
Ramasamy, Ranjith
Bivalacqua, Trinity J.
Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title_full Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title_fullStr Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title_full_unstemmed Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title_short Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA)
title_sort restorative therapies for erectile dysfunction: position statement from the sexual medicine society of north america (smsna)
topic Society Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240368/
https://www.ncbi.nlm.nih.gov/pubmed/34000480
http://dx.doi.org/10.1016/j.esxm.2021.100343
work_keys_str_mv AT liujamesl restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT chukeviny restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT gabrielsonandrewt restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT wangrun restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT trostlandon restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT broderickgregory restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT davieskelvin restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT brockgerald restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT mulhalljohn restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT ramasamyranjith restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna
AT bivalacquatrinityj restorativetherapiesforerectiledysfunctionpositionstatementfromthesexualmedicinesocietyofnorthamericasmsna